Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARLY: Carboplatin in Early TNBC
NCT02441933Phase 3Active, not recruiting
- Sponsor
- Yonsei University
- Start
- Sep 2015
- Primary completion
- Jun 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple-negative breast cancer (TNBC), sponsored by Yonsei University. Started Sep 2015; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02441933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441933.